MI enhances osteoblast function and inhibits osteoclast differentiation via RANKL-mediated pathways, while DCI and its derivative D-pinitol reduce osteoclast activity, particularly in conditions like postmenopausal osteoporosis and diabetes-related bone loss. This evidence concerns the gene TNFSF11 and postmenopausal osteoporosis.